Korea Investment Corp Biomarin Pharmaceutical Inc Transaction History

Korea Investment Corp

  • $43.6 Billion
  • Q2 2025

A detailed history of Korea Investment Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Korea Investment Corp holds 241,603 shares of BMRN stock, worth $13.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
241,603
Previous 214,903 12.42%
Holding current value
$13.4 Million
Previous $15.2 Million 12.58%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$54.08 - $68.32 $1.44 Million - $1.82 Million
26,700 Added 12.42%
241,603 $13.3 Million
Q1 2025

May 14, 2025
BUY
$61.25 - $72.83 $2.88 Million - $3.42 Million
47,000 Added 27.99%
214,903 $15.2 Million
Q4 2024

Feb 12, 2025
BUY
$61.93 - $70.49 $8.15 Million - $9.28 Million
131,600 Added 362.5%
167,903 $11 Million
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $1.44 Million - $1.96 Million
-20,838 Reduced 36.47%
36,303 $2.55 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $1.99 Million - $2.46 Million
-26,686 Reduced 31.83%
57,141 $4.7 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $2.65 Million - $3.13 Million
31,576 Added 60.43%
83,827 $7.32 Million
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $92,149 - $119,098
-1,209 Reduced 2.26%
52,251 $5.04 Million
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $1.02 Million - $1.13 Million
-11,952 Reduced 18.27%
53,460 $4.73 Million
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $632,503 - $731,889
7,297 Added 12.56%
65,412 $5.67 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $3.14 Million - $4.19 Million
-35,740 Reduced 38.08%
58,115 $5.65 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $1.19 Million - $1.6 Million
14,713 Added 18.59%
93,855 $9.71 Million
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $2.39 Million - $2.82 Million
-29,119 Reduced 26.9%
79,142 $6.71 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $1.86 Million - $2.26 Million
26,061 Added 31.7%
108,261 $8.97 Million
Q1 2022

May 13, 2022
BUY
$74.28 - $92.69 $3.39 Million - $4.24 Million
45,700 Added 125.21%
82,200 $6.34 Million
Q4 2021

Feb 09, 2022
SELL
$71.72 - $91.47 $1.18 Million - $1.5 Million
-16,400 Reduced 31.0%
36,500 $3.23 Million
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $680,407 - $777,777
9,100 Added 20.78%
52,900 $4.09 Million
Q2 2021

Aug 12, 2021
BUY
$75.51 - $84.79 $234,081 - $262,849
3,100 Added 7.62%
43,800 $3.66 Million
Q1 2021

May 13, 2021
SELL
$74.73 - $90.69 $769,719 - $934,107
-10,300 Reduced 20.2%
40,700 $3.07 Million
Q4 2020

Feb 10, 2021
SELL
$72.61 - $90.2 $290,440 - $360,800
-4,000 Reduced 7.27%
51,000 $4.47 Million
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $14,374 - $26,206
200 Added 0.36%
55,000 $4.18 Million
Q2 2020

Aug 12, 2020
SELL
$79.55 - $124.22 $198,875 - $310,550
-2,500 Reduced 4.36%
54,800 $6.76 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $2.25 Million - $3.05 Million
31,500 Added 122.09%
57,300 $4.84 Million
Q4 2019

Feb 11, 2020
SELL
$64.27 - $86.37 $70,697 - $95,007
-1,100 Reduced 4.09%
25,800 $2.18 Million
Q3 2019

Nov 12, 2019
BUY
$67.4 - $85.11 $60,660 - $76,599
900 Added 3.46%
26,900 $1.81 Million
Q2 2019

Aug 12, 2019
SELL
$80.35 - $93.9 $2.46 Million - $2.87 Million
-30,600 Reduced 54.06%
26,000 $2.23 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $4.6 Million - $5.38 Million
54,579 Added 2700.59%
56,600 $5.03 Million
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $1.73 Million - $1.94 Million
-18,390 Reduced 90.1%
2,021 $196,000
Q1 2018

May 09, 2018
BUY
$77.67 - $92.63 $1.46 Million - $1.74 Million
18,816 Added 1179.69%
20,411 $1.66 Million
Q3 2017

Oct 25, 2017
BUY
$80.6 - $94.95 $128,556 - $151,445
1,595
1,595 $148,000

Others Institutions Holding BMRN

# of Institutions
675
Shares Held
185M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email